Table 2.

Distribution of neuropathological outcomes.

Neuropathological outcome	Final sample (n = 129)
Cerebrovascular pathology
Present cortical infarcts, n (%)	12 (9.3%)
Present subcortical infarcts, n (%)	25 (19.4%)
Atherosclerosis
None, n (%)	29 (22.5%)
Mild, n (%)	67 (51.9%)
Moderate, n (%)	24 (18.6%)
Severe, n (%)	9 (7.0%)
Arteriosclerosis
None, n (%)	36 (28.1%)
Mild, n (%)	47 (36.7%)
Moderate, n (%)	33 (25.8%)
Severe, n (%)	12 (9.4%)
Proteinopathy
Braak stage
Stage 0–I, n (%)	29 (22.5%)
Stage II, n (%)	32 (24.8%)
Stage III, n (%)	26 (20.2%)
Stage IV, n (%)	12 (9.3%)
Stage V, n (%)	15 (11.6%)
Stage VI, n (%)	15 (11.6%)
Cerebral amyloid angiopathy
None, n (%)	29 (22.5%)
Mild, n (%)	67 (51.9%)
Moderate, n (%)	24 (18.6%)
Severe, n (%)	9 (7.0%)
CERAD neuritic plaque score
None, n (%)	34 (26.4%)
Sparse, n (%)	37 (28.7%)
Moderate, n (%)	27 (20.9%)
Frequent, n (%)	31 (24.0%)